Production (Stage)
bluebird bio, Inc.
BLUE
$4.97
-$0.01-0.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.24% | 52.78% | 25.29% | -16.60% | 13.63% |
| Total Depreciation and Amortization | 11.78% | -9.38% | -7.15% | 6.83% | 74.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.29% | -5.00% | -20.41% | 73.36% | -55.60% |
| Change in Net Operating Assets | 6.62% | -31.23% | -109.58% | 41.61% | -978.95% |
| Cash from Operations | 13.40% | 27.22% | -4.04% | 11.28% | -37.94% |
| Capital Expenditure | -77.11% | -73.21% | -374.58% | 96.68% | -46.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.27% | 295.44% | -55.60% | 50.00% | -77.60% |
| Cash from Investing | 25.84% | 428.97% | -71.25% | 347.48% | -117.30% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -71.12% | 21.77% | 20.82% | -19.02% | -57.88% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6.55% | 246.45% | -27.23% | 31.12% | 542.90% |
| Cash from Financing | -23.67% | 673.14% | -0.73% | -109.38% | -39.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.25% | 82.96% | -5.48% | -561.54% | -119.00% |